EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role of Kynurenine-Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) axis in migraine pathophysiology and therapy

Tamás Körtési iD, Lilla Ajkay-Donáth, Evelin Vágvölgyi-Sümegi iD, Zoltán Tapody iD, Noémi Varga, Rita Kis-György iD, Délia Szok iD, Gábor Nagy-Grócz iD, János Tajti iD, László Vécsei iD

Ideggyógyászati szemle · 2026 · 79 (7-8) · 231-245

DOI: 10.18071/isz.79.0231 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ideggyógyászati szemle, 2026. Verfasst von Tamás Körtési und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Theoretical Health Sciences and Health Management, Faculty of Health Sciences and Social Studies, University of Szeged, Szeged. Hauptthemen laut MEDLINE: Migraine Disorders, Kynurenine, Pituitary Adenylate Cyclase-Activating Polypeptide.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Migraine is one of the most common types of primary headaches, and its pathomecha nism is not yet fully understood. Our know ledge of its pathophysiology has previously focused primarily on the serotonin system; however, in recent years, increa sing attention has been given to tryptophan metabolism, particularly the Kynurenine pathway (KP). The KP, which is involved in the regulation of glutamatergic neurotransmission, is responsible for the synthesis of several neuroprotective and neurotoxic metabolites. Kynurenic acid (KYNA) is endogenous glutamate NMDA receptor antagonist in the body. Experimental data indicate that KYNA plays an important role in the pathophysiology of migraine attacks. Preclinical studies support that KYNA and its synthetic analogs are able to inhibit the pathological processes occur ring during migraine. Our previous clinical studies have confirmed that in patients with migraine, the balance maintained by neuroprotective and neurotoxic KP metabolites is disrupted, affecting both the protective and the toxic side. It is important to note, however, that various molecules of KP metabolism can exert both positive and negative effects depending on their concentration at multiple sites of the body, and therefore there is no international consensus regarding the spectrum of protective and toxic molecules. Recently, "migraine associated" neuropeptides have emerged as another promising target for migraine therapy. Calcitonin gene related peptide (CGRP) and pituitary adenylate cyclase activating polypeptide (PACAP) are involved, among other process es, in nociception and neurogenic inflammation, and their expression is altered duringmigraine attacks. Monoclonal antibody therapies targeting these neuropeptides are currently considered the most promising treatment for migraine. Our experimental data have demonstrated a close correla tion between the kynurenine pathway (KP), PACAP, and CGRP signaling, which suggests that investigation of these systems together may offer a new approach to understanding the pathological processes underlying migraine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersKynureninePituitary Adenylate Cyclase-Activating PolypeptideHumansAnimals

Stichwörter der Autor:innen

PACAPkynure nine metabolismmigraineneuropeptidestryptophan

Substanzen

KynureninePituitary Adenylate Cyclase-Activating Polypeptide

Autor:innen und Institutionen

  • Department of Theoretical Health Sciences and Health Management, Faculty of Health Sciences and Social Studies, University of Szeged, Szeged.
  • HUN-REN-SZTE Neuroscience Research Group, University of Szeged, Szeged.
  • Preventive Health Sciences Research Group, Incubation Competence Centre of the Centre of Excellence for Interdisciplinary Research, Development and Innovation of the University of Szeged, Szeged.
  • Doctoral School of Experimental and Preventive Medicine, University of Szeged, Szeged.
  • Department of Neurology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged.
  • Section of Health Behaviour and Health Promotion, Faculty of Health Sciences and Social Studies, University of Szeged, Szeged.

ORCID-Profile: Tamás Körtési, Evelin Vágvölgyi-Sümegi, Zoltán Tapody, Rita Kis-György, Délia Szok, Gábor Nagy-Grócz, János Tajti, László Vécsei

Zitieren

APA

Körtési, T., Ajkay-Donáth, L., Vágvölgyi-Sümegi, E., Tapody, Z., Varga, N., Kis-György, R., Szok, D., Nagy-Grócz, G., Tajti, J., & Vécsei, L. (2026). The role of Kynurenine-Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) axis in migraine pathophysiology and therapy. Ideggyógyászati szemle, 79(7-8), 231-245. https://doi.org/10.18071/isz.79.0231

Vancouver

Körtési T, Ajkay-Donáth L, Vágvölgyi-Sümegi E, Tapody Z, Varga N, Kis-György R, et al. The role of Kynurenine-Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) axis in migraine pathophysiology and therapy. Ideggyógyászati szemle. 2026;79(7-8):231-245. doi:10.18071/isz.79.0231

BibTeX
@article{Krtsi2026,
  author = {Körtési, Tamás and Ajkay-Donáth, Lilla and Vágvölgyi-Sümegi, Evelin and Tapody, Zoltán and Varga, Noémi and Kis-György, Rita and Szok, Délia and Nagy-Grócz, Gábor and Tajti, János and Vécsei, László},
  title = {The role of Kynurenine-Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) axis in migraine pathophysiology and therapy},
  journal = {Ideggyógyászati szemle},
  year = {2026},
  volume = {79},
  number = {7-8},
  pages = {231--245},
  doi = {10.18071/isz.79.0231}
}
Kostenlos starten →